Groupon (GRPN) Q2 Revenue Beats by 3%

Groupon (GRPN) reported stronger-than-expected Q2 2025 earnings, with GAAP revenue of $125.7 million surpassing analyst estimates and a significant rebound to $0.46 GAAP EPS from a prior-year loss. This positive performance was primarily driven by robust growth in its North America Local business, which saw gross billings increase 20%, alongside improved cost discipline and strong free cash flow generation of $25.2 million. However, overall revenue growth remained modest at 0.9% year-over-year due to compressed take rates and persistent softness in international markets, where billings declined, indicating continued progress in its transformation efforts despite regional disparities.

Analysis

Groupon's Q2 2025 results illustrate a pivotal stage in its transformation, characterized by a stark divergence between profitability metrics and top-line growth. The company significantly beat analyst expectations with a GAAP EPS of $0.46, a dramatic reversal from a $0.25 loss in the prior-year quarter, and GAAP revenue of $125.7 million. This bottom-line strength was driven by disciplined cost management and robust free cash flow generation of $25.2 million. Operationally, the North America Local segment is the clear engine of progress, posting a 20% increase in gross billings and a 6% rise in active customers. However, this momentum is not reflected in headline revenue, which grew a mere 0.9% year-over-year. This disconnect is a direct result of management's strategy to compress take rates to improve merchant value, a move that masks the 12% growth in underlying gross billings. The positive domestic story is further tempered by persistent weakness in international markets, which saw a 3% decline in billings and an 11% drop in active customers, alongside a continued strategic retreat from the non-core Goods category. The lack of explicit forward guidance places the burden on investors to interpret these conflicting signals, weighing the successful turnaround in the core North American business against international headwinds and a revenue model under strategic transition.

Key Decisions for Investors

• Investors should view the 12% growth in gross billings and strong free cash flow as leading indicators of the transformation's health, potentially justifying a bullish stance if they believe the current take rate compression is a temporary, strategic investment for long-term market share.
• Monitor the performance of international markets closely, as the 11% year-over-year decline in active international customers represents a significant risk to achieving sustainable global growth.
• Given the lack of formal guidance and a 13.4% rise in marketing spend, it is critical to track the trajectory of billings versus revenue growth to assess if take rates are stabilizing and to gauge the return on investment for customer acquisition efforts in coming quarters.